Element Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-105,840
Closed -$7.39M 62
2023
Q3
$7.39M Sell
105,840
-63,034
-37% -$4.47M 0.66% 43
2023
Q2
$11.7M Buy
168,874
+8,801
+5% +$626K 0.79% 33
2023
Q1
$11.9M Buy
+160,073
New +$13.4M 0.9% 33
2022
Q1
Sell
-557,369
Closed -$57.5M 140
2021
Q4
$57.5M Buy
+557,369
New +$51.5M 3.7% 9
2019
Q1
Sell
-161,749
Closed -$10.6M 848
2018
Q4
$10.6M Buy
161,749
+51,392
+47% +$3.84M 0.3% 68
2018
Q3
$8.69M Buy
110,357
+79,601
+259% +$5.69M 0.17% 116
2018
Q2
$1.98M Buy
30,756
+19,140
+165% +$1.26M 0.05% 157
2018
Q1
$723K Sell
11,616
-956,584
-99% -$68.6M 0.02% 248
2017
Q4
$70.2M Buy
+968,200
New +$70.4M 1.44% 4
2016
Q3
Sell
-93,050
Closed -$8.91M 88
2016
Q2
$8.91M Sell
93,050
-8,341
-8% -$831K 1.35% 18
2016
Q1
$10.5M Buy
101,391
+77,968
+333% +$7.58M 1.56% 13
2015
Q4
$2.29M Buy
23,423
+1,373
+6% +$134K 0.45% 37
2015
Q3
$2.13M Buy
22,050
+15,750
+250% +$1.66M 0.77% 25
2015
Q2
$661K Buy
+6,300
New +$644K 0.24% 44

Other funds holding CVS

Element Capital Management's CVS Position: Q4 2023 in Review

Element Capital Management sold out of CVS Health (CVS) in Q4 2023, closing a stake of 105,840 shares — an estimated $7.39M sold.

Element Capital Management first reported a position in CVS in Q2 2015 and held it in 14 quarters. The position peaked at $70.2M in Q4 2017. 2,257 funds tracked by Wall St. Rank hold CVS as of Q4 2023.

  • Element Capital Management reported no remaining CVS Health position as of Q4 2023 after selling out during the quarter.
  • Element Capital Management sold 105,840 CVS Health shares in Q4 2023, an estimated $7.39M.
  • Element Capital Management first reported a position in CVS Health in Q2 2015 and held it in 14 quarters.
  • Element Capital Management's CVS Health position peaked at $70.2M in Q4 2017.
  • 2,257 funds tracked by Wall St. Rank held CVS Health as of Q4 2023.

Based on Element Capital Management's 13F filing for Q4 2023, filed 9 Feb 2024.